TY - JOUR
T1 - Acenocoumarol or warfarin
T2 - Which is the clinician’s ally?
AU - Karthik Rao, N.
AU - Patil, Navin
AU - Avinash, A.
AU - Hande, Handattu Manjunatha
AU - Kunder, Sushil Kiran
AU - Raghavendra Rao, N.
N1 - Publisher Copyright:
© 2016, Asian Journal of Pharmaceutical and Clinical Research. All rights reserved.
PY - 2016/3/1
Y1 - 2016/3/1
N2 - Warfarin and acenocoumarol are commonly prescribed oral anticoagulant drugs that are used in the prevention and treatment of thromboembolic disorders across the world. Although both these drugs act by a similar mechanism, there are significant differences between them, especially in terms of their half-lives, and more importantly, in their variability in response pharmacogenetically. This case report highlights an instance wherein warfarin proved to provide a much more stable anticoagulant cover, as compared to that provided by acenocoumarol.
AB - Warfarin and acenocoumarol are commonly prescribed oral anticoagulant drugs that are used in the prevention and treatment of thromboembolic disorders across the world. Although both these drugs act by a similar mechanism, there are significant differences between them, especially in terms of their half-lives, and more importantly, in their variability in response pharmacogenetically. This case report highlights an instance wherein warfarin proved to provide a much more stable anticoagulant cover, as compared to that provided by acenocoumarol.
UR - https://www.scopus.com/pages/publications/84960089700
UR - https://www.scopus.com/inward/citedby.url?scp=84960089700&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84960089700
SN - 0974-2441
VL - 9
SP - 4
EP - 5
JO - Asian Journal of Pharmaceutical and Clinical Research
JF - Asian Journal of Pharmaceutical and Clinical Research
IS - 2
ER -